These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1149 related articles for article (PubMed ID: 7474333)

  • 61. [Antibiotic susceptibility of bacteria isolated from surgical infections (first report)].
    Yura J; Shinagawa N; Ishikawa S; Hayasaka H; Shiramatsu K; Ishibiki K; Aikawa N; Suzuki H; Takahashi T; Sakai K
    Jpn J Antibiot; 1986 Oct; 39(10):2557-78. PubMed ID: 3543430
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). III. Secular changes in susceptibility].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Nov; 48(11):1671-756. PubMed ID: 8558756
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2004)].
    Goto H; Takeda H; Kawai S; Watanabe T; Okazaki M; Shimada K; Nakano K; Yokouchi H; Ikemoto H; Mori T; Igari J; Oguri T; Yamamoto M; Inoue H; Nakadate T; Suwabe A; Ashino Y; Gejyo F; Okada M; Aoki N; Kitamura N; Suzuki Y; Karasawa Y; Kudo K; Kobayashi N; Tanaka T; Sumitomo M; Matsushima T; Oka M; Niki Y; Suga M; Tosaka M; Kohno S; Hirakata Y; Kondou A; Matsuda J; Nakano M; Nasu M; Hiramatsu K; Oikawa S
    Jpn J Antibiot; 2006 Oct; 59(5):323-54. PubMed ID: 17180803
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1983). I. Susceptibility distribution].
    Kosakai N; Igari J; Kumamoto Y; Sakai S; Shigeta S; Shiraiwa Y; Abe K; Tazaki H; Iri H; Uchida H
    Jpn J Antibiot; 1985 Aug; 38(8):2185-229. PubMed ID: 4079003
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Basic and clinical studies on tazobactam/piperacillin in pediatric field].
    Motohiro T; Nagai K; Yamada T; Oki S; Yamada T; Yoshinaga Y; Tsumura N; Oda K; Sakata Y; Kato H; Imai S; Morita J; Matsuo Y; Ikezawa S; Takahgashi K; Fukuda T; Yamashita Y; Aramaki M; Hayashi M; Yamakawa R; Ono-E ; Tananari Y; Tsutsumi T; Hoshuyama A; Aida K
    Jpn J Antibiot; 1998 Jun; 51(6):413-31. PubMed ID: 9755831
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Evaluation of in vitro antimicrobial activity of cefazolin alone and in combination with cefmetazole or flomoxef using agar dilution method and disk diffusion method].
    Matsuo K; Uete T
    Jpn J Antibiot; 1992 Oct; 45(10):1253-66. PubMed ID: 1479676
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1991)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kondou T; Kobayashi K; Satou K; Matsumiya H; Saito A
    Jpn J Antibiot; 1995 Aug; 48(8):965-98. PubMed ID: 7474326
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparative "in vitro" activity of ciprofloxacin (Bay o9867) and other antimicrobial agents against urinary bacterial isolates.
    Piccolomini R; Ravagnan G
    Chemioterapia; 1986 Aug; 5(4):249-56. PubMed ID: 3769047
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Nationwide survey on susceptibilities of clinical isolates to antibacterial agents in 1991].
    Tabe Y; Igari J
    Jpn J Antibiot; 1995 Mar; 48(3):409-20. PubMed ID: 7752454
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
    Matsuzaki K; Koyama H; Chiba A; Omika K; Harada S; Sato Y; Hasegawa M; Kobayashi I; Kaneko A; Sasaki J
    Jpn J Antibiot; 1999 Sep; 52(9):571-84. PubMed ID: 10746192
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Antimicrobial susceptibilities of organisms isolated from patients with urinary tract infections in 2002].
    Eta S; Kawahara M
    Jpn J Antibiot; 2006 Feb; 59(1):21-8. PubMed ID: 16673579
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antibiotic sensitivity of recent clinical isolates from patients with ocular infections.
    Ooishi M; Miyao M
    Ophthalmologica; 1997; 211 Suppl 1():15-24. PubMed ID: 9065933
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Antibacterial activities of piperacillin in several fresh clinical isolates].
    Matsuzaki K; Koyama H; Omika K; Hasegawa M; Sato Y; Kobayashi I; Kaku M
    Jpn J Antibiot; 2000 Aug; 53(8):573-81. PubMed ID: 11070819
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Bacteria isolated from surgical infections and its susceptibilities to antimicrobial agents--Special references to bacteria isolated between July 1982 and March 2012].
    Shinagawa N; Iwasaki M
    Jpn J Antibiot; 2015 Jun; 68(3):151-87. PubMed ID: 26349116
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [In vitro antibacterial activity of various cephems against clinical isolates from complicated urinary tract infections].
    Kamidono S; Fujii A; Arakawa S; Kataoka N; Ishigami J
    Jpn J Antibiot; 1985 Jan; 38(1):179-89. PubMed ID: 3989977
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). II. Background of patients].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Sep; 48(9):1161-73. PubMed ID: 7474334
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection.
    Farrell DJ; Morrissey I; De Rubeis D; Robbins M; Felmingham D
    J Infect; 2003 Feb; 46(2):94-100. PubMed ID: 12634070
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Antimicrobial activities of meropenem against clinically isolated strains. The result against strains isolated from blood and cerebrospinal fluid].
    Deguchi K; Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Oda S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1996 Apr; 49(4):377-85. PubMed ID: 8786628
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
    Nishino T; Otsuki M; Hatano K; Nishihara Y
    Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Clinical laboratory approach to estimating the effective administration dose of imipenem/cilastatin. Evaluation of the disk susceptibility test and its interpretation system].
    Matsuo K; Uete T
    Jpn J Antibiot; 1989 Nov; 42(11):2377-92. PubMed ID: 2621780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.